|
| 36756380 | ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma<sup/>. | Hum Reprod Open | 2023 |
| 37154838 | Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience. | J Assist Reprod Genet | 2023 |
| 37202317 | Preimplantation genetic testing for mitochondrial DNA mutation: ovarian response to stimulation, outcomes and follow-up. | Reprod Biomed Online | 2023 |
| 37475164 | Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis. | Hum Reprod | 2023 |
| 37331510 | [News in assisted reproductive technologies after French Bioethic law of 2021 August]. | Gynecol Obstet Fertil Senol | 2023 |
| 36961937 | The follicular output rate in normo-ovulating women undergoing ovarian stimulation is increased after unilateral oophorectomy. | Hum Reprod | 2023 |
| 36860186 | Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation. | Hum Reprod | 2023 |
| 36752941 | Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM. | J Assist Reprod Genet | 2023 |
| 36652119 | Correction to: Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer. | J Assist Reprod Genet | 2023 |
| 36473609 | Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer. | Fertil Steril | 2023 |
| 36746507 | ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. | Int J Gynecol Cancer | 2023 |
| 36739613 | ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. | Facts Views Vis Obgyn | 2023 |
| 36765851 | Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in <i>BRCA</i>-Pathogenic-Variant-Positive Breast Cancer Patients. | Cancers (Basel) | 2023 |
| 34815159 | Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma. | Reprod Biomed Online | 2022 |
| 35586947 | Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation. | Hum Reprod | 2022 |
| 35767167 | Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer. | J Assist Reprod Genet | 2022 |
| 35461885 | Fertility of tomorrow: Are there any restrictions left? | Ann Endocrinol (Paris) | 2022 |
| 35690817 | Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger? | Reprod Biol Endocrinol | 2022 |
| 36497251 | Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to <i>BRCA</i> Pathogenic Variant Carriers? | Cancers (Basel) | 2022 |
| 35932626 | What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. | Eur J Cancer | 2022 |
| 35914708 | Fertility preservation in teenage girls, for non- oncological indications. | J Gynecol Obstet Hum Reprod | 2022 |
| 35241291 | Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review. | Gynecol Oncol | 2022 |
| 33262005 | Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF). | Eur J Obstet Gynecol Reprod Biol | 2021 |
| 33797007 | Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience. | J Assist Reprod Genet | 2021 |
| 34785697 | Impact of oxygen tension according to embryo stage of development: a prospective randomized study. | Sci Rep | 2021 |
| 34575343 | Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women. | J Clin Med | 2021 |
| 34568938 | What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome? | Hum Reprod | 2021 |
| 34650912 | Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy. | Front Oncol | 2021 |
| 34218388 | Perspectives on the development and future of oocyte IVM in clinical practice. | J Assist Reprod Genet | 2021 |
| 34040586 | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus. | Front Endocrinol (Lausanne) | 2021 |
| 34068748 | Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis. | Int J Mol Sci | 2021 |
| 34037751 | Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women? | Hum Reprod | 2021 |
| 33144266 | Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. | J Gynecol Obstet Hum Reprod | 2021 |
| 33400960 | Cryopreservation of small numbers of human spermatozoa in a Stripper tip: Report of the first live-birth worldwide. | Cryobiology | 2021 |
| 33160106 | Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers. | J Gynecol Obstet Hum Reprod | 2021 |
| 33272625 | Telomere aberrations, including telomere loss, doublets, and extreme shortening, are increased in patients with infertility. | Fertil Steril | 2021 |
| 33415529 | Women utilizing oocyte donation have a decreased live birth rate if they displayed a low progesterone level in a previous hormonal replacement mock cycle. | J Assist Reprod Genet | 2021 |
| 32395637 | ESHRE guideline: ovarian stimulation for IVF/ICSI<sup>â¿ </sup>. | Hum Reprod Open | 2020 |
| 32085890 | First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer. | Ann Oncol | 2020 |
| 32047010 | Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial. | BMJ Open | 2020 |
| 32065670 | In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions. | Hematol Oncol | 2020 |
| 32004782 | [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility]. | Gynecol Obstet Fertil Senol | 2020 |
| 32004780 | [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text]. | Gynecol Obstet Fertil Senol | 2020 |
| 33409381 | Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI. | Hum Reprod Open | 2020 |
| 33122722 | Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible. | Sci Rep | 2020 |
| 32920265 | Use of the EFI score in endometriosis-associated infertility: A cost-effectiveness study. | Eur J Obstet Gynecol Reprod Biol | 2020 |
| 32805629 | First follow-up of art pregnancies in the context of the COVID-19 outbreak. | Eur J Obstet Gynecol Reprod Biol | 2020 |
| 32889113 | National survey on the opinions of French specialists in assisted reproductive technologies about social issues impacting the future revision of the French Bioethics laws. | J Gynecol Obstet Hum Reprod | 2020 |
| 32970695 | Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French survey. | PLoS One | 2020 |
| 32709383 | In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency. | Fertil Steril | 2020 |